Detalhe da pesquisa
1.
Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: meta-analysis.
Br J Surg
; 111(5)2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801441
2.
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study).
BMC Cancer
; 24(1): 91, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233810
3.
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy.
Br J Cancer
; 129(6): 1022-1031, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507543
4.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589839
5.
An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer.
BMC Cancer
; 23(1): 171, 2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803350
6.
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
J Neurooncol
; 163(2): 327-338, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237151
7.
Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 24(13)2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445722
8.
BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Br J Cancer
; 127(3): 488-499, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501389
9.
AMPK-regulated miRNA-210-3p is activated during ischaemic neuronal injury and modulates PI3K-p70S6K signalling.
J Neurochem
; 159(4): 710-728, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694332
10.
Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19).
Thorax
; 76(1): 86-88, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097604
11.
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.
Breast Cancer Res Treat
; 189(1): 269-283, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125341
12.
Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer.
J Transl Med
; 19(1): 184, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933113
13.
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
BMC Cancer
; 21(1): 140, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33557783
14.
Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenograft models of metastatic colorectal cancer.
Int J Cancer
; 147(10): 2891-2901, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700762
15.
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples.
J Transl Med
; 18(1): 99, 2020 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087721
16.
Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A.
Invest New Drugs
; 38(5): 1365-1372, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32318883
17.
Dynamic platelet function is markedly different in patients with cancer compared to healthy donors.
Platelets
; 30(6): 737-742, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252557
18.
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro.
BMC Cancer
; 18(1): 168, 2018 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29426295
19.
BCL-2 system analysis identifies high-risk colorectal cancer patients.
Gut
; 66(12): 2141-2148, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27663504
20.
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
Breast Cancer Res
; 19(1): 87, 2017 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28750640